SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Weber R, Sabin CA, Friis-Moller N, Reiss P, El Sadr WM, Kirk O, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006; 166: 1632-1641.
  • 2
    Centers for Disease Control and Prevention. Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men—New York City, 2005–2010. MMWR Morb Mortal Wkly Rep 2011; 60: 945-950.
  • 3
    Terrault NA, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, et al. Outcomes of liver transplantation in HCV-HIV coinfected recipients. Liver Transpl 2012; 18: 716-726.
  • 4
    Rodriguez-Torres M, Slim J, Bhatti L, Sterling R, Sulkowski M, Hassanein T, et al. Peginterferon alfa-2a plus ribavirin for HIV-HCV genotype 1 coinfected patients: a randomized international trial. HIV Clin Trials 2012; 13: 142-152.
  • 5
    Poordad F, McCone J, Bacon BR, Bruno S, Manns MP, Sulkowski MS, et al. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011; 364: 1195-1206.
  • 6
    Bacon BR, Gordon SC, Lawitz E, Marcellin P, Vierling JM, Zeuzem S, et al. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med 2011; 364: 1207-1217.
  • 7
    Mark S, Pol S, Cooper C, Fainboim H, Slim J, Rivero, A, et al. Boceprevir + pegylated interferon + ribavirin for the treatment of HCV/HIV-coinfected patients: end of treatment (week 48) interim results. In: Proceedings of the 19th Conference on Retroviruses and Opportunistic Infections; March 6, 2012; Seattle, WA. Abstract.
  • 8
    Victrelis (Boceprevir) Prescribing Information. Whitehouse Station, NJ: Merck & Co.; 2012.
  • 9
    Jacobson IM, McHutchison JG, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, et al. Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med 2011; 364: 2405-2416.
  • 10
    Dieterich D, Soriano V, Sherman K, Girard P-M, Rockstroh J, Adiwijaya B, et al. Telaprevir in combination with pegylated interferon-a-2a + RBV in HCV/HIV-co-infected patients: a 24-week treatment interim analysis. In: Proceedings of the 19th Conference on Retroviruses and Opportunistic Infections; March 6, 2012; Seattle, WA. Abstract.
  • 11
    Incivek (Telaprevir) Prescribing Information. Cambridge, MA: Vertex Pharmaceuticals; 2012.
  • 12
    AIDSinfo. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. http://www.aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment-guidelines/26/hepatitis-c–hcv–hiv-coinfection. Published March 2012. Accessed June 2012.